Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from AFT Pharmaceuticals Ltd. ( (AU:AFP) ) is now available.
AFT Pharmaceuticals Ltd. announced a change in the shareholding of its director, Hartley Campbell Atkinson, due to an inheritance from the estate of Mrs. IJ Atkinson. This transaction involved the acquisition of 17,755 ordinary shares at zero consideration, slightly increasing Atkinson’s stake in the company. This development reflects internal adjustments within the company’s leadership and may have implications for its governance and shareholder structure.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is known for its over-the-counter medicines and prescription drugs, serving both domestic and international markets.
Average Trading Volume: 3,079
Technical Sentiment Signal: Sell
Current Market Cap: A$246.8M
For an in-depth examination of AFP stock, go to TipRanks’ Overview page.